Skip navigation | ||
|
||
Medical Encyclopedia |
|
Other encyclopedia topics: | A-Ag Ah-Ap Aq-Az B-Bk Bl-Bz C-Cg Ch-Co Cp-Cz D-Di Dj-Dz E-Ep Eq-Ez F G H-Hf Hg-Hz I-In Io-Iz J K L-Ln Lo-Lz M-Mf Mg-Mz N O P-Pl Pm-Pz Q R S-Sh Si-Sp Sq-Sz T-Tn To-Tz U V W X Y Z 0-9 |
Contents of this page: | |
|
Definition Return to top
The parathyroids are four glands in the neck that produce parathyroid hormone (PTH) to help control calcium use by the body.
Too much production of PTH caused by increased activity of these glands is known as hyperparathyroidism. When this occurs in response to low blood calcium that is caused by another condition, the hyperparathyroidism condition is called secondary hyperparathyroidism.
Causes Return to top
Parathyroid hormone helps maintain blood calcium by regulating bone turnover, absorption of calcium from the gut, and release of calcium in the urine.
Many disorders may lead to secondary hyperparathyroidism by causing hypocalcemia (low levels of calcium in the blood), a phosphate imbalance, or both. These include the following:
At-risk populations include children with malnutrition and elderly people with little sun exposure.
Chronic renal failure is an important cause of secondary hyperparathyroidism. The disorder is complex:
Bone is broken down in an attempt to regulate abnormal levels of the above chemicals, and the high levels of phosphates in the blood rise higher. These conditions cause further secondary hyperparathyroidism.
Symptoms Return to top
Symptoms generally relate to the underlying cause of secondary hyperparathyroidism.
In children, rickets may cause the following:
Patients with kidney failure may have osteomalacia, osteoporosis, or both. Bone pain or fractures may occur.
Symptoms of malabsorption (such as diarrhea) or of an underlying cancer may occur in patients with those disorders.
Exams and Tests Return to top
Signs may include bone deformities, swollen joints, or fractures.
Tests may show:
Treatment Return to top
Treatment involves correcting the underlying cause of the secondary hyperparathyroidism.
Patients with vitamin D deficiency are treated with vitamin D, or with other measures to correct malabsorption. Patients with cancer are usually treated surgically. Patients with chronic kidney failure are usually treated with calcium supplementation, phosphate restriction, and vitamin D analogs. Dialysis, kidney transplantation, or parathyroid surgery may be needed.
Outlook (Prognosis) Return to top
The outcome for secondary hyperparathyroidism depends on the underlying cause.
When treated, rickets generally has a good prognosis. Other causes of secondary hyperparathyroidism have variable outcomes.
Possible Complications Return to top
Tertiary hyperparathyroidism may occur in some patients with kidney failure. In these cases, hypercalcemia (elevated levels of calcium) may develop with calcium supplementation, and surgery on the parathyroids may become necessary.
Renal osteodystrophy is another potential complication. This is a variable syndrome comprising osteomalacia, osteoporosis, secondary hyperparathyroidism, or osteosclerosis. Bone pain, weakness, and fractures are part of the syndrome.
When to Contact a Medical Professional Return to top
Call your health care provider if you have symptoms of this disorder, particularly if you are being treated for kidney disease.
Prevention Return to top
Early detection of rickets or vitamin D deficiency may prevent secondary hyperparathyroidism.
Treatment of patients with kidney failure helps minimize secondary hyperparathyroidism.
Update Date: 8/8/2006 Updated by: Robert Hurd, MD, Department of Biology, College of Arts and Sciences, Xavier University, Cincinnati, OH. Review provided by VeriMed Healthcare Network
Home | Health Topics | Drugs & Supplements | Encyclopedia | Dictionary | News | Directories | Other Resources | |
Copyright | Privacy | Accessibility | Quality Guidelines U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894 National Institutes of Health | Department of Health & Human Services |
Page last updated: 02 January 2008 |